The test, run on Abbott (ABT)'s portable i-STAT ® Alinity ® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), or concussion The test produces ...

IRVINE, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic products, today announced it has received U.S. Food ...

The U.S. Army Medical Materiel Development Activity’s Warfighter Protection and Acute Care Project Management Office, along with its commercial partner BioFire Defense, announced the U.S. Food and ...

Since the start of the pandemic, the FDA has issued emergency use authorizations to a whopping 444 diagnostic tests and sample collection devices to detect the COVID-19 virus. In recent months, ...

A blood test that can predict whether pregnant women are at risk of developing preeclampsia, one of the world's leading causes of maternal death and disability, recently received clearance from the ...

Switzerland-based Roche this week said it has received U.S. regulatory clearance for an Alzheimer’s blood test. This test is used in primary care offices for a patient’s initial assessment of ...

This illustration picture shows a saliva collection kit for DNA testing displayed in Washington DC on December 19, 2018. - Between 2015 and 2018, sales of DNA test kits boomed in the United States and ...

New test will run on Abbott's Alinity® i laboratory instrument, complementing Abbott's rapid i-STAT TBI Plasma test, cleared by the FDA in 2021 Given the significant number of Alinity i instruments in ...

Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...

PCMag editors select and review products independently. If you buy through affiliate links, we may earn commissions, which help support our testing. AST SpaceMobile can finally start testing its ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EUROIMMUN’s automated ...